Kacip Fatimah (Labisia pumila)
What Is Kacip Fatimah?
Kacip Fatimah is catalogued in the Materia Medica under the binomial Labisia pumila, a plant of the Primulaceae family, native to the rainforests of Malaysia and Indonesia. The material in circulation is whole plant (root, leaf) — an underground part, harvested once the plant has drawn its reserves down. Most people search for it simply as Kacip Fatimah; suppliers, pharmacopoeias and interaction databases list it as Labisia pumila, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as earthy, mildly bitter, green — a practical marker of freshness and correct identification.
The written history of Kacip Fatimah begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the whole plant (root, leaf) contains. Beyond its practical use it carries cultural associations — fatimah, the prophet's daughter, is the namesake — feminine resilience tonic.
Today most searches for Kacip Fatimah come from people reading about stress relief, menopause, energy and bone health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is postpartum uterine involution support, followed by phytoestrogenic — eases menopausal symptoms (small RCTs).
How Does Kacip Fatimah Work?
Kacip Fatimah works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in whole plant (root, leaf) rather than by one marker molecule.
Traditional practice described Kacip Fatimah in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on norhaiza et al. Where research exists, it examines postpartum uterine involution support, phytoestrogenic — eases menopausal symptoms (small RCTs) and bone-density preservation in animal models. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Kacip Fatimah is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Kacip Fatimah is documented as interacting with hormone therapy and tamoxifen. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Kacip Fatimah can differ substantially; this is why reference entries specify whole plant (root, leaf) and, where they exist, standardisation markers.